The life sciences industry is abuzz with the potential of generative AI, but its application in the highly regulated pharmaceutical sector faces challenges. As Jane Lomax, Ph.D., head of ontologies at Elsevier’s SciBite subsidiary notes, “Everyone across the whole industry is experimenting with it. But no one knows for sure yet how best to use…